| Target Price | $359.55 |
| Price | $370.16 |
| Deviation | 2.87% |
| Number of Estimates | 28 |
| 28 Analysts have issued a price target American Express 2026 . The average American Express target price is $359.55. This is 2.87% lower than the current stock price. The highest price target is $420.00 13.46% , the lowest is $272.40 26.41% . | |
| A rating was issued by 36 analysts: 14 Analysts recommend American Express to buy, 21 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the American Express stock has an average upside potential 2026 of 2.87% . Most analysts recommend the American Express stock at Hold. |
27 Analysts have issued a sales forecast American Express 2025 . The average American Express sales estimate is $72.9b . This is 4.02% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $76.1b 0.22% , the lowest is $70.4b 7.25% .
This results in the following potential growth metrics:
| 2024 | $71.6b | 6.35% |
|---|---|---|
| 2025 | $72.9b | 1.69% |
| 2026 | $79.3b | 8.88% |
| 2027 | $86.1b | 8.50% |
| 2028 | $88.8b | 3.15% |
| 2029 | $95.1b | 7.12% |
4 Analysts have issued an American Express EBITDA forecast 2025. The average American Express EBITDA estimate is $26.9b . This is 76.58% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $28.0b 83.57% , the lowest is $26.1b 71.34% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $14.1b | 13.28% |
|---|---|---|
| 2025 | $26.9b | 91.21% |
| 2026 | $18.8b | 29.98% |
| 2027 | $24.7b | 31.02% |
| 2024 | 19.63% | 6.51% |
|---|---|---|
| 2025 | 36.90% | 88.01% |
| 2026 | 23.73% | 35.69% |
| 2027 | 28.66% | 20.78% |
32 American Express Analysts have issued a net profit forecast 2025. The average American Express net profit estimate is $10.8b . This is 3.27% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $11.3b 8.47% , the lowest is $10.3b 0.77% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $10.0b | 21.12% |
|---|---|---|
| 2025 | $10.8b | 7.57% |
| 2026 | $12.1b | 12.75% |
| 2027 | $13.8b | 14.24% |
| 2028 | $14.0b | 1.35% |
| 2029 | $15.1b | 7.49% |
| 2024 | 13.95% | 13.89% |
|---|---|---|
| 2025 | 14.76% | 5.80% |
| 2026 | 15.28% | 3.52% |
| 2027 | 16.09% | 5.30% |
| 2028 | 15.81% | 1.74% |
| 2029 | 15.86% | 0.32% |
32 Analysts have issued a American Express forecast for earnings per share. The average American Express EPS is $15.60 . This is 3.86% higher than earnings per share in the financial year 2024. The highest EPS forecast is $16.39 9.12% , the lowest is $14.99 0.20% .
This results in the following potential growth metrics and future valuations:
| 2024 | $14.02 | 25.07% |
|---|---|---|
| 2025 | $15.60 | 11.27% |
| 2026 | $17.59 | 12.76% |
| 2027 | $20.10 | 14.27% |
| 2028 | $20.37 | 1.34% |
| 2029 | $21.90 | 7.51% |
| Current | 24.49 | 17.18% |
|---|---|---|
| 2025 | 23.57 | 3.77% |
| 2026 | 20.91 | 11.29% |
| 2027 | 18.30 | 12.48% |
| 2028 | 18.06 | 1.31% |
| 2029 | 16.80 | 6.98% |
Based on analysts' sales estimates for 2025, the American Express stock is valued at an EV/Sales of 5.63 and an P/S ratio of 3.48 .
This results in the following potential growth metrics and future valuations:
| Current | 5.41 | 9.96% |
|---|---|---|
| 2025 | 5.63 | 4.13% |
| 2026 | 5.17 | 8.16% |
| 2027 | 4.77 | 7.83% |
| 2028 | 4.62 | 3.06% |
| 2029 | 4.32 | 6.65% |
| Current | 3.34 | 15.76% |
|---|---|---|
| 2025 | 3.48 | 4.19% |
| 2026 | 3.19 | 8.16% |
| 2027 | 2.94 | 7.83% |
| 2028 | 2.85 | 3.06% |
| 2029 | 2.66 | 6.65% |
American Express...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Freedom Capital Markets |
Sell
➜
Hold
|
Upgrade | Oct 24 2025 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 20 2025 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Oct 20 2025 |
| Truist Securities |
Buy
➜
Buy
|
Unchanged | Oct 20 2025 |
| BTIG |
Sell
➜
Sell
|
Unchanged | Oct 20 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Oct 07 2025 |
| JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Oct 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Upgrade
Freedom Capital Markets:
Sell
➜
Hold
|
Oct 24 2025 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 20 2025 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Oct 20 2025 |
|
Unchanged
Truist Securities:
Buy
➜
Buy
|
Oct 20 2025 |
|
Unchanged
BTIG:
Sell
➜
Sell
|
Oct 20 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Oct 07 2025 |
|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Oct 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


